About this document
Filgotinib Efficacy in Rheumatoid Arthritis by Yoo An is a document available to read on EtoBox.
The document describes two clinical trials that tested the efficacy, safety, pharmacokinetics, and pharmacodynamics of filgotinib, a selective JAK-1 inhibitor, in patients with rheumatoid arthritis. The trials showed that treatment with filgotinib met the primary endpoint of efficacy and had an encouraging safety profile, with no worsening of side effects seen with less selective JAK inhibitors. Selective inhibition of JAK-1 with filgotinib demonstrated initial efficacy in rheumatoid arthritis patients.
- Author
- Yoo An
- Language
- EN